Cargando…

Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report

RATIONALE: Primary neuroendocrine tumors (NETs) of the retroperitoneum are extremely rare. The purpose of this case report is to highlight the unusual growth pattern and radiologic features of primary retroperitoneal NETs. PATIENT CONCERNS: A 46-year-old woman was found to have a retroperitoneal cys...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Dan, Dong, Guo-Qiu, Shen, Ke-Ren, Pan, Yao, Wei, Shu-Mei, Chen, Ying, Yu, Ri-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808506/
https://www.ncbi.nlm.nih.gov/pubmed/33466160
http://dx.doi.org/10.1097/MD.0000000000024054
_version_ 1783636913053237248
author Shi, Dan
Dong, Guo-Qiu
Shen, Ke-Ren
Pan, Yao
Wei, Shu-Mei
Chen, Ying
Yu, Ri-Sheng
author_facet Shi, Dan
Dong, Guo-Qiu
Shen, Ke-Ren
Pan, Yao
Wei, Shu-Mei
Chen, Ying
Yu, Ri-Sheng
author_sort Shi, Dan
collection PubMed
description RATIONALE: Primary neuroendocrine tumors (NETs) of the retroperitoneum are extremely rare. The purpose of this case report is to highlight the unusual growth pattern and radiologic features of primary retroperitoneal NETs. PATIENT CONCERNS: A 46-year-old woman was found to have a retroperitoneal cystic and solid mass during a physical checkup. DIAGNOSES: The mass was mainly multiseptated in the cystic portion and had a bead-like, lobulated appearance. The solid portion showed restricted diffusion on diffusion-weighted imaging and obvious homogeneous enhancement. The cystic portion showed ring-like and septal enhancement. The patient was diagnosed with a grade 2 (G2) NET of the retroperitoneum after surgery. INTERVENTIONS: The patient underwent resection of the large retroperitoneal tumor. OUTCOMES: The patient returned 20 months later with tumor recurrence in the retroperitoneum. She was enrolled in a clinical trial for sulfatinib, and the mass was considerably reduced in size after 4 months. During a nearly 1.5-year follow-up, the mass gradually became slightly enlarged. The expression of somatostatin receptor 2 (SSTR2) was detected, and somatuline was administered as the current treatment. LESSONS SUBSECTIONS: When a retroperitoneal mass presents as a well-defined cystic or solid hypervascular mass with a fibrous capsule, a primary retroperitoneal NET should be considered in the differential diagnosis.
format Online
Article
Text
id pubmed-7808506
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78085062021-01-15 Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report Shi, Dan Dong, Guo-Qiu Shen, Ke-Ren Pan, Yao Wei, Shu-Mei Chen, Ying Yu, Ri-Sheng Medicine (Baltimore) 6800 RATIONALE: Primary neuroendocrine tumors (NETs) of the retroperitoneum are extremely rare. The purpose of this case report is to highlight the unusual growth pattern and radiologic features of primary retroperitoneal NETs. PATIENT CONCERNS: A 46-year-old woman was found to have a retroperitoneal cystic and solid mass during a physical checkup. DIAGNOSES: The mass was mainly multiseptated in the cystic portion and had a bead-like, lobulated appearance. The solid portion showed restricted diffusion on diffusion-weighted imaging and obvious homogeneous enhancement. The cystic portion showed ring-like and septal enhancement. The patient was diagnosed with a grade 2 (G2) NET of the retroperitoneum after surgery. INTERVENTIONS: The patient underwent resection of the large retroperitoneal tumor. OUTCOMES: The patient returned 20 months later with tumor recurrence in the retroperitoneum. She was enrolled in a clinical trial for sulfatinib, and the mass was considerably reduced in size after 4 months. During a nearly 1.5-year follow-up, the mass gradually became slightly enlarged. The expression of somatostatin receptor 2 (SSTR2) was detected, and somatuline was administered as the current treatment. LESSONS SUBSECTIONS: When a retroperitoneal mass presents as a well-defined cystic or solid hypervascular mass with a fibrous capsule, a primary retroperitoneal NET should be considered in the differential diagnosis. Lippincott Williams & Wilkins 2021-01-15 /pmc/articles/PMC7808506/ /pubmed/33466160 http://dx.doi.org/10.1097/MD.0000000000024054 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 6800
Shi, Dan
Dong, Guo-Qiu
Shen, Ke-Ren
Pan, Yao
Wei, Shu-Mei
Chen, Ying
Yu, Ri-Sheng
Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report
title Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report
title_full Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report
title_fullStr Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report
title_full_unstemmed Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report
title_short Primary cystic and solid neuroendocrine tumor of the retroperitoneum: A case report
title_sort primary cystic and solid neuroendocrine tumor of the retroperitoneum: a case report
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808506/
https://www.ncbi.nlm.nih.gov/pubmed/33466160
http://dx.doi.org/10.1097/MD.0000000000024054
work_keys_str_mv AT shidan primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport
AT dongguoqiu primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport
AT shenkeren primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport
AT panyao primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport
AT weishumei primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport
AT chenying primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport
AT yurisheng primarycysticandsolidneuroendocrinetumoroftheretroperitoneumacasereport